AQR Capital Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $334K | Sell |
|
|||||
|
2025
Q2 | $1.72M | Sell |
|
|||||
|
2025
Q1 | $3.44M | Sell |
|
|||||
|
2024
Q4 | $21.5M | Buy |
|
|||||
|
2024
Q3 | $29.1M | Buy |
|
|||||
|
2024
Q2 | $3.61M | Buy |
|
|||||
|
2024
Q1 | $3.27M | Sell |
|
|||||
|
2023
Q4 | $883K | Sell |
|
|||||
|
2023
Q3 | $616K | Buy |
|
|||||
|
2023
Q2 | $509K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $354K | Buy |
|
|||||
|
2022
Q1 | $132K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $275K | Buy |
|
|||||
|
2019
Q1 | $327K | Sell |
|
|||||
|
2018
Q4 | $261K | Sell |
|
|||||
|
2018
Q3 | $1.06M | Sell |
|
|||||
|
2018
Q2 | $754K | Buy |
|